Future FinTech unit signs framework agreement to acquire TransGen SC Tech

Future FinTech (FTFT)announced that on January 7, 2026, its wholly-owned subsidiary, Future FinTech Limited, signed a Framework Agreement that outlines preliminary terms for its acquisition of 100% of the shares of TransGen SC Tech Limited. Pursuant to the Agreement, the acquisition is expected to be completed within 90 calendar days subject to due diligence and a financial audit of TransGen. A formal acquisition agreement will be executed upon a satisfactory outcome, after which both parties will sign a definitive agreement. TransGen has established a solid foundation in biofactor R&D, which entails processes that leverage naturally occurring compounds that support normal physiological functioning and that have health-promoting effects on disease prevention and overall wellness. TransGen’s primary focus is on the high-value therapeutic areas of developing treatments for diabetes and Alzheimer’s disease.